Literature DB >> 16212811

Expression of hypoxia-inducible carbonic anhydrases in brain tumors.

Martin A Proescholdt1, Christina Mayer, Marion Kubitza, Thomas Schubert, Shu-Yuan Liao, Eric J Stanbridge, Sergey Ivanov, Edward H Oldfield, Alexander Brawanski, Marsha J Merrill.   

Abstract

Malignant brain tumors exhibit distinct metabolic characteristics. Despite high levels of lactate, the intracellular pH of brain tumors is more alkaline than normal brain. Additionally, with increasing malignancy, brain tumors display intratumoral hypoxia. Carbonic anhydrase (CA) IX and XII are transmembrane isoenzymes that are induced by tissue hypoxia. They participate in regulation of pH homeostasis by catalyzing the reversible hydration of carbon dioxide. The aim of our study was to investigate whether brain tumors of different histology and grade of malignancy express elevated levels of CA IX and XII as compared to normal brain. We analyzed 120 tissue specimens from brain tumors (primary and metastatic) and normal brain for CA IX and XII expression by immunohistochemistry, Western blot, and in situ hybridization. Whereas normal brain tissue showed minimal levels of CA IX and XII expression, expression in tumors was found to be upregulated with increased level of malignancy. Hemangioblastomas, from patients with von Hippel-Lindau disease, also displayed high levels of CA IX and XII expression. Comparison of CA IX and XII staining with HIF-1alpha staining revealed a similar microanatomical distribution, indicating hypoxia as a major, but not the only, induction factor. The extent of CA IX and XII staining correlated with cell proliferation, as indicated by Ki67 labeling. The results demonstrate that CA IX and XII are upregulated in intrinsic and metastatic brain tumors as compared to normal brain tissue. This may contribute to the management of tumor-specific acid load and provide a therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16212811      PMCID: PMC1871734          DOI: 10.1215/S1152851705000025

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  54 in total

Review 1.  Metabolism of the malignant astrocytoma.

Authors:  J R Mangiardi; P Yodice
Journal:  Neurosurgery       Date:  1990-01       Impact factor: 4.654

2.  In vivo imaging of glucose consumption and lactate concentration in human gliomas.

Authors:  K Herholz; W Heindel; P R Luyten; J A denHollander; U Pietrzyk; J Voges; H Kugel; G Friedmann; W D Heiss
Journal:  Ann Neurol       Date:  1992-03       Impact factor: 10.422

3.  pH distributions in transplanted neural tumors and normal tissues of BDIX rats as measured with pH microelectrodes.

Authors:  E Jähde; M F Rajewsky; H Baumgärtl
Journal:  Cancer Res       Date:  1982-04       Impact factor: 12.701

4.  In vivo measurement of regional brain tissue pH using positron emission tomography.

Authors:  D A Rottenberg; J Z Ginos; K J Kearfott; L Junck; D D Bigner
Journal:  Ann Neurol       Date:  1984       Impact factor: 10.422

5.  Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole.

Authors:  P E Valk; C A Mathis; M D Prados; J C Gilbert; T F Budinger
Journal:  J Nucl Med       Date:  1992-12       Impact factor: 10.057

6.  In vivo measurement of brain tumor pH using [11C]DMO and positron emission tomography.

Authors:  D A Rottenberg; J Z Ginos; K J Kearfott; L Junck; V Dhawan; J O Jarden
Journal:  Ann Neurol       Date:  1985-01       Impact factor: 10.422

7.  Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications.

Authors:  P C Burger; F S Vogel; S B Green; T A Strike
Journal:  Cancer       Date:  1985-09-01       Impact factor: 6.860

8.  In vivo measurement of regional brain and tumor pH using [14C]dimethyloxazolidinedione and quantitative autoradiography.

Authors:  J B Arnold; L Junck; D A Rottenberg
Journal:  J Cereb Blood Flow Metab       Date:  1985-09       Impact factor: 6.200

Review 9.  The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis.

Authors:  Christopher William Pugh; Peter John Ratcliffe
Journal:  Semin Cancer Biol       Date:  2003-02       Impact factor: 15.707

10.  Human primary brain tumour metabolism in vivo: a phosphorus magnetic resonance spectroscopy study.

Authors:  T A Cadoux-Hudson; M J Blackledge; B Rajagopalan; D J Taylor; G K Radda
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

View more
  31 in total

1.  Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines.

Authors:  Harun M Said; Adrian Staab; Carsten Hagemann; Giles H Vince; Astrid Katzer; Michael Flentje; Dirk Vordermark
Journal:  J Neurooncol       Date:  2006-08-31       Impact factor: 4.130

Review 2.  Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding.

Authors:  Vijay M Krishnamurthy; George K Kaufman; Adam R Urbach; Irina Gitlin; Katherine L Gudiksen; Douglas B Weibel; George M Whitesides
Journal:  Chem Rev       Date:  2008-03       Impact factor: 60.622

Review 3.  Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?

Authors:  Stefan Kaluz; Milota Kaluzová; Shu-Yuan Liao; Michael Lerman; Eric J Stanbridge
Journal:  Biochim Biophys Acta       Date:  2009-01-22

Review 4.  Carbonic anhydrases as disease markers.

Authors:  Sabina Zamanova; Ahmed M Shabana; Utpal K Mondal; Marc A Ilies
Journal:  Expert Opin Ther Pat       Date:  2019-06-17       Impact factor: 6.674

5.  Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas.

Authors:  David Taïeb; Anne Barlier; Chunzhang Yang; Morgane Pertuit; Aurélie Tchoghandjian; Claire Rochette; Hélène Zattara-Canoni; Dominique Figarella-Branger; Zhengping Zhuang; Karel Pacak; Philippe Metellus
Journal:  J Neurooncol       Date:  2015-10-29       Impact factor: 4.130

Review 6.  Carbonic anhydrase XII functions in health and disease.

Authors:  Abdul Waheed; William S Sly
Journal:  Gene       Date:  2017-04-19       Impact factor: 3.688

Review 7.  Intrinsically disordered features of carbonic anhydrase IX proteoglycan-like domain.

Authors:  Emma Langella; Martina Buonanno; Giuseppina De Simone; Simona Maria Monti
Journal:  Cell Mol Life Sci       Date:  2020-11-17       Impact factor: 9.261

8.  The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis.

Authors:  Kristiina Nordfors; Joonas Haapasalo; Miikka Korja; Anssi Niemelä; Jukka Laine; Anna-Kaisa Parkkila; Silvia Pastorekova; Jaromir Pastorek; Abdul Waheed; William S Sly; Seppo Parkkila; Hannu Haapasalo
Journal:  BMC Cancer       Date:  2010-04-18       Impact factor: 4.430

9.  Involvement of histone deacetylation in MORC2-mediated down-regulation of carbonic anhydrase IX.

Authors:  Yangguang Shao; Yan Li; Jian Zhang; Di Liu; Furong Liu; Yue Zhao; Tao Shen; Feng Li
Journal:  Nucleic Acids Res       Date:  2010-01-27       Impact factor: 16.971

10.  Function of carbonic anhydrase IX in glioblastoma multiforme.

Authors:  Martin A Proescholdt; Marsha J Merrill; Eva-Maria Stoerr; Annette Lohmeier; Fabian Pohl; Alexander Brawanski
Journal:  Neuro Oncol       Date:  2012-10-16       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.